Insiders who reported open-market trades in the last 12 months at the companies Andrew Guggenhime files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Grant Pickering - $3.63M in PCVX purchases and sales in the last 12 months
Jim Wassil - $3.12M in PCVX purchases and sales in the last 12 months
Elvia Cowan - $2.08M in PCVX purchases and sales in the last 12 months
Andrew Guggenhime is a corporate insider, tracked as PRESIDENT AND CFO of Vaxcyte, Inc. (PCVX). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Guggenhime submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Andrew Guggenhime been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($7.88M) across all tracked filings.
Andrew Guggenhime is PRESIDENT AND CFO of Vaxcyte, Inc. (PCVX). 17 SEC Form 4 filings on record going back to 2024, most recently on 9 September 2026. Most recent open-market trade: sold $165K of PCVX on 5 August 2026. Lifetime open-market sales: $7.88M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Andrew Guggenhime.
InsiderAlpha's records for Andrew Guggenhime go back to 2024: 17 primary Form 4 filings, an average of 5.7 per year. 32 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
